208 related articles for article (PubMed ID: 29214448)
21. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
22. Qualitative Heterogeneous Signal Drop on Chemical Shift (CS) MR Imaging: Correlative Quantitative Analysis between CS Signal Intensity Index and Contrast Washout Parameters Using T1-Weighted Sequences.
Stanzione A; Verde F; Galatola R; Romeo V; Liuzzi R; Mainenti PP; Aprea G; Klain M; Guadagno E; Del Basso De Caro M; Maurea S
Tomography; 2021 Dec; 7(4):961-971. PubMed ID: 34941651
[TBL] [Abstract][Full Text] [Related]
23. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold?
Ho LM; Paulson EK; Brady MJ; Wong TZ; Schindera ST
AJR Am J Roentgenol; 2008 Jul; 191(1):234-8. PubMed ID: 18562751
[TBL] [Abstract][Full Text] [Related]
24. Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas.
Tu W; Abreu-Gomez J; Udare A; Alrashed A; Schieda N
Radiol Imaging Cancer; 2020 Nov; 2(6):e200011. PubMed ID: 33778748
[TBL] [Abstract][Full Text] [Related]
25. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
26. [Value of single-source dual-energy CT (ssDECT) in differentiating lipid-poor adrenal adenomas from metastatic lesions].
Ju Y; Liu AL; Wang HQ; Liu YJ; Liu JH; Chen AL; Chen LH; Li Y; Han Z
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):826-832. PubMed ID: 27998440
[No Abstract] [Full Text] [Related]
27. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
28. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
[TBL] [Abstract][Full Text] [Related]
29. ADC histogram analysis for adrenal tumor histogram analysis of apparent diffusion coefficient in differentiating adrenal adenoma from pheochromocytoma.
Umanodan T; Fukukura Y; Kumagae Y; Shindo T; Nakajo M; Takumi K; Nakajo M; Hakamada H; Umanodan A; Yoshiura T
J Magn Reson Imaging; 2017 Apr; 45(4):1195-1203. PubMed ID: 27571307
[TBL] [Abstract][Full Text] [Related]
30. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging.
Chung JJ; Semelka RC; Martin DR
J Magn Reson Imaging; 2001 Feb; 13(2):242-8. PubMed ID: 11169830
[TBL] [Abstract][Full Text] [Related]
31. Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: can biopsy be obviated?
Slapa RZ; Jakubowski W; Januszewicz A; Kasperlik-Zaluska AA; Dabrowska E; Fijuth J; Feltynowski T; Tarnawski R; Królicki L
Eur Radiol; 2000; 10(1):95-104. PubMed ID: 10663723
[TBL] [Abstract][Full Text] [Related]
32. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
33. [Scintigraphic characterization of expansive lesions located in the adrenals. Comparison with magnetic resonance imaging].
Maurea S; Klain M; Lastoria S; Caracò C; Castelli L; Varrella P; Filice S; Rossi R; Salvatore M
Radiol Med; 1995 Dec; 90(6):756-65. PubMed ID: 8685460
[TBL] [Abstract][Full Text] [Related]
34. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
35. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
36. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
37. Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.
Park JJ; Park BK; Kim CK
Br J Radiol; 2016 Jun; 89(1062):20151018. PubMed ID: 26867466
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
Friedrich-Rust M; Schneider G; Bohle RM; Herrmann E; Sarrazin C; Zeuzem S; Bojunga J
AJR Am J Roentgenol; 2008 Dec; 191(6):1852-60. PubMed ID: 19020259
[TBL] [Abstract][Full Text] [Related]
39. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
40. Pitfalls of adrenal imaging with chemical shift MRI.
Schieda N; Al Dandan O; Kielar AZ; Flood TA; McInnes MD; Siegelman ES
Clin Radiol; 2014 Nov; 69(11):1186-97. PubMed ID: 25062926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
